/

Investors / Japan / Catalys Pacific

Catalys Pacific

Venture capital · Tokyo, Japan · Asia Pacific

catalyspacific.com

Catalys Pacific is an investment and company-building firm that creates and develops new biotech companies on both sides of the Pacific. It combines a global network with local presence in Japan and the United States to source early-stage opportunities and build bespoke biotech companies.

Invests inHealthcare & Biotech

In its own wordsbiotechtherapeuticscompany buildinghealthcarelife sciences

Your fit with Catalys Pacific

Four questions about your startup

See how your round matches what it backs, point by point.

Or find every investor that fits
1portfolio companies
2funding rounds on record
1rounds, last 12 months
$100M or moretypical round it comes in at
Series Amost frequent entry

Catalys Pacific lists 1 checked portfolio company on its own site and is named in 2 funding rounds. Its most frequent entry is Series A, 100% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 100% of its companies are based in United States. It invests most often alongside AN Venture Partners, Frazier Life Sciences and Lightstone Ventures.

Counts come from funding rounds that name Catalys Pacific, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.

Entry stage

share of companies by the stage of its first round
Show as a table
Share of companies by the stage of the firm's first round
Value
Pre-seed0%
Seed0%
Series A100%
Series B0%
Growth0%

Activity by year

rounds it joined, last 10 years
Show as a table
Funding rounds per year
TotalRounds it led
'1700
'1800
'1900
'2000
'2100
'2200
'2300
'2400
'2510
'2610

Invests most often with

firms sharing its portfolio companies
Show as a table
Co-investors
Share
AN Venture Partners1
Frazier Life Sciences1
Lightstone Ventures1
Longwood Fund1
Pivotal Life Sciences1
Pontifax1
SBI Investment Korea1
SR One1

All co-investors

Its portfolio companies

where they are based, and what their own sites show

Headquarters

Site status

  • Site answers1100%
  • No longer answers00%
  • Points to another company00%
  • Parked or sold domain00%

A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.

Investment themes

share of its checked companies

This firmAll checked companies

Show as a table
Investment themes
This firmAll checked companies
Healthcare & Biotech100%15%

Co-investor network

who it backs companies with, and who they back together
6 shared companies5 shared companies3 shared companies3 shared companies3 shared companies2 shared companies2 shared companies2 shared companies2 shared companies2 shared companies2 shared companies2 shared companiesAN Venture Partners: 1 shared companiesAN Venture Partners1Frazier Life Sciences: 1 shared companiesFrazier Life Sciences1Lightstone Ventures: 1 shared companiesLightstone Ventures1Longwood Fund: 1 shared companiesLongwood Fund1Pivotal Life Sciences: 1 shared companiesPivotal Life Sciences1Pontifax: 1 shared companiesPontifax1SBI Investment Korea: 1 shared companiesSBI Investment Korea1SR One: 1 shared companiesSR One1Soleus Capital: 1 shared companiesSoleus Capital1Xontogeny: 1 shared companiesXontogeny1
Shared portfolio companies with Catalys PacificFirms that also back companies together

All co-investors or Compare portfolios with AN Venture Partners

Compare Catalys Pacific head to head

portfolio size, rounds, entry stages, themes and the companies both back

Three or more firms at once: portfolio overlap.

Recent portfolio activity

when companies last raised with Catalys Pacific
DateCompanyStage
22 Jul 2026Crystalys Therapeuticscrystalystx.comSeries B
30 Sept 2025Crystalys Therapeuticscrystalystx.comSeries A

Round details for Catalys Pacific

Amounts, full round histories and every co-investor in Catalys Pacific's rounds are on Fundup AI. VCinfo covers investors and their portfolios.

See rounds on Fundup AI →

Portfolio

1 company checked against their own sites
CompanyWhat it doesThemesFirst round with itEvidence
Crystalys Therapeuticscrystalystx.com · United StatesCrystalys Therapeutics develops new therapeutics to address unmet medical needs, specifically for people living with gout.
Healthcare & Biotech
Sept 2025Series A · 2 roundsFunding round

About this data

site last read 5 Nov 2026
The homepage of Catalys Pacific, as last read
catalyspacific.com as VCinfo last read it
Site
catalyspacific.com
Last read
5 Nov 2026
Watching since
6 Nov 2026
Rounds since
30 Sept 2025
Companies checked
1

Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.

How we grade the data

Free account · no card

Get Catalys Pacific's profile as data

Pull Catalys Pacific's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/catalyspacific.com

# also
GET /v1/firms/catalyspacific.com/portfolio
GET /v1/firms/catalyspacific.com/coinvestors
GET /v1/firms/catalyspacific.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing